Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06717165 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Mechanism of Augmentation of Cognitive Behavioral Therapy With Transcranial Alternating Current Stimulation(tACS) for Obsessive-Compulsive Disorder (OCD)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 120 to 62
    • Study description expanded, about 103 words
    • Study arms: 3 to 2
    • Eligibility criteria expanded, about 2 words
    v3
  2. Primary endpoint revisedv2 Show 5 more changesShow less
    • Trial status: Enrolling by Invitation to Recruiting
    • Eligibility criteria shortened, about 28 words
    • Study description revised
    • Site details revised
    • Study title revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the feasibility and clinical outcome of the Exposure-based Cognitive-Behavioral Therapy (CBT) concurrent with Transcranial Alternating Current Stimulation (tACS) using individualized stimulation frequency in treating obsessive-compulsive disorder (OCD) patients, and explores the potential neural mechanisms of treatment effect by magnetic resonance imaging (MRI) and electroencephalography (EEG).
Trial Details
NCT Number NCT06717165
Lead Sponsor Shanghai Mental Health Center
Conditions
(from sponsor)		 Obsessive Compulsive Disorder (OCD)
Related terms Obsessive-Compulsive Disorder
Enrollment 62 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov